[Clinical and experimental validation of the use of the tranquilizer mebikar as a corrective of the neuroleptic syndrome].
The results of the experimental and clinical studies showed that administration of mebikar in combination with neuroleptics reduced the degree of side effects of the neuroleptics without decreasing their antipsychotic effect.
Zimakova
I E
IE
Semenikhin
D G
DG
Karpov
A M
AM
Kirshin
S V
SV
D000818:Animals; D001736:Biureas / Q000009:adverse effects / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D003214:Conditioning, Classical / Q000187:drug effects; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004924:Escape Reaction / Q000187:drug effects; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D051381:Rats
D001736:Biureas; C015979:mebikar; D006220:Haloperidol; D002746:Chlorpromazine
Kliniko-éksperimental'noe obonosvanie primeneniia trankvilizatora mebikara v kachestve korrektora neĭrolepticheskogo sindroma.